ERIS

ERIS LIFESCIENCES

Mid Cap BSE: 540596 NSE: ERIS
₹700.00
1.4 (0.2%)
As on 30 September, 2022 | 03:34

Eris Lifesciences Share Price

Eris Lifesciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in ERIS LIFESCIENCES

Start SIP

Eris Lifesciences Share Returns

  • Over 1 Month 1.43%
  • Over 3 Month 7.3%
  • Over 6 Month 1.43%
  • Over 1 Year -6.54%

Eris Lifesciences Key Statistics

P/E Ratio 24.2
PEG Ratio 4.2
Market Cap Cr 9,519
Price to Book Ratio 5
EPS 30.8
Dividend 1
Relative Strength Index 52.87
Money Flow Index 67.79
MACD Signal 3.01
Average True Range 19.61

Eris Lifesciences Investment Rating

  • Master Rating:
  • Eris Lifesciences has an operating revenue of Rs. 1,396.36 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 33% is great, ROE of 21% is exceptional. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 1% and 0% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 18% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 65 which is a FAIR score but needs to improve its earnings, a RS Rating of 36 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 155 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Eris Lifesciences Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 322277300323306257
Operating Expenses Qtr Cr 203181182186184163
Operating Profit Qtr Cr 12610212313712394
Depreciation Qtr Cr 151514121110
Interest Qtr Cr 711100
Tax Qtr Cr 12810131117
Net Profit Qtr Cr 968710412010769

Eris Lifesciences Technicals

EMA & SMA

Current Price
700.
1.4 (0.2%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 696.43
  • 50 Day
  • 690.11
  • 100 Day
  • 687.08
  • 200 Day
  • 691.83
  • 20 Day
  • 698.19
  • 50 Day
  • 691.14
  • 100 Day
  • 677.51
  • 200 Day
  • 691.61

Eris Lifesciences Resistance and Support

PIVOT
₹694.19
Resistance
First Resistance 708.37
Second Resistance 718.14
Third Resistance 732.32
RSI 52.87
MFI 67.8
MACD Single Line 3.01
MACD 1.97
Support
First Resistance 684.42
Second Resistance 670.24
Third Resistance 660.47

Eris Lifesciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 55,219 4,132,038 74.83
Week 44,641 2,832,497 63.45
1 Month 35,128 1,978,758 56.33
6 Month 77,935 4,713,528 60.48

Eris Lifesciences Result Highlights

Eris Lifesciences Synopsis

NSE-Medical-Biomed/Biotech

Eris Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1215.73 Cr. and Equity Capital is Rs. 13.59 Cr. for the Year ended 31/03/2022. Eris Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ2007PLC049867 and registration number is 049867.
Market Cap 9,519
Sales 1,238
Shares in Float 6.53
No of funds 114
Yield 1.05
Book Value 4.96
U/D Vol ratio 1.4
LTDebt / Equity
Alpha -0.02
Beta 0.56

Eris Lifesciences

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 52.3%52.66%52.66%
Mutual Funds 10.36%10.11%9.99%
Foreign Portfolio Investors 15.35%13.31%13.34%
Financial Institutions/ Banks
Individual Investors 21.34%23.14%23.19%
Others 0.65%0.78%0.82%

Eris Lifesciences Management

Name Designation
Mr. Amit Bakshi Chairperson & Managing Director
Mr. Krishnakumar Vaidyanathan COO & Executive Director
Mr. Inderjeet Singh Negi Executive Director
Mr. Kaushal Shah Executive Director
Mr. Rajeev Dalal Independent Director
Mr. Vasudevan Sujesh Independent Director
Ms. Kalpana Unadkat Independent Director
Mr. Prashant Gupta Independent Director

Eris Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eris Lifesciences Corporate Action

Date Purpose Remarks
2022-08-05 Quarterly Results & Interim Dividend
2022-05-03 Audited Results
2022-01-28 Quarterly Results
2021-10-29 Quarterly Results
2021-07-29 Quarterly Results & Interim Dividend
Date Purpose Remarks
2022-08-16 INTERIM Rs.7.35 per share(735%)Interim Dividend
2021-08-06 INTERIM Rs.6.01 per share(601%)Interim Dividend

Eris Lifesciences MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 26503
Kotak Emerging Equity Scheme Growth 21935
Aditya Birla Sun Life Equity Hybrid '95 Fund Growth 8025
Franklin India Smaller Companies Fund Growth 7033
UTI Value Opportunities Fund Regular Plan Growth 6923

Eris Lifesciences FAQs

What is Share Price of Eris Lifesciences ?

Eris Lifesciences share price is ₹700 As on 30 September, 2022 | 03:20

What is the Market Cap of Eris Lifesciences ?

The Market Cap of Eris Lifesciences is ₹9519.3 Cr As on 30 September, 2022 | 03:20

What is the P/E ratio of Eris Lifesciences ?

The P/E ratio of Eris Lifesciences is 24.2 As on 30 September, 2022 | 03:20

What is the PB ratio of Eris Lifesciences ?

The PB ratio of Eris Lifesciences is 5 As on 30 September, 2022 | 03:20

Q1FY23